Development and strategy analysis of Chinese herbal medicine in Germany
10.3760/cma.j.cn115398-20220518-00254
- VernacularTitle:中草药在德国的发展概况与建议
- Author:
Haoyue LI
1
;
Jing ZHAO
;
Zijun ZHANG
;
Xueyang ZHANG
;
Xiaoying TONG
;
Masseli CHRISTINE
;
Yisheng ZHANG
;
Chen LIU
;
Haiyu XU
;
Rongrong GAO
Author Information
1. 中国中医科学院国际合作处，北京 100700
- Keywords:
Drugs, Chinese herbal;
Germany;
International cooperation;
Analysis;
Development strategy
- From:
International Journal of Traditional Chinese Medicine
2022;44(11):1215-1220
- CountryChina
- Language:Chinese
-
Abstract:
Germany owns the largest herbal market in Europe and has the world's leading R&D capabilities for herbal medicine products. Chinese herbal medicine (CHM) spreaded to Germany hundreds of years ago. Since the beginning of the 20th century, China and Germany have signed a series of agreements to support traditional medicine cooperation, and the exchange of herbs between China and Germany has become more frequent, bringing opportunities for CHM to enter into Germany. In recent years, China and Germany have gained progress in the fields of CHM research and trade, etc. However, there are differences in the understanding of herbal medicines, quality standard evaluation, usage, and medication rules between the two countries. By doing SWOT analysis of the development of CHM in Germany, this paper suggested to promote Sino-German medical exchanges and build a community of common health for mankind through strengthening the clinical application of CHM, finding new ways of CHM entering into German market, and building an international talent team of traditional Chinese medicine.
